2017 ACVIM Forum Research Abstract Program

Probability of remission was lower than often documented in referral populations. High mortality following DM diagnosis and owner reluctance to pursue medical therapy present substantial barriers to achieving greater diabetic remission rates in primarycare practice. Increased likelihood of diabetic remission has not been previously identified in Burmese cats. This could result from differences in the pathogenesis of DM in Burmese compared to other breed types and warrants further investigation. Long-acting insulin treatment is recommended in feline diabetes mellitus (DM) and insulin glargine has frequently been proposed to offer the greatest efficacy and likelihood of diabetic remission.